So, at the end of a week of wild swings, what have we learned about this trade. Or is this just sort of a blip in the bigger AI trade. Tim, what do you think.>> Uh, no. I look, I think the last month has been important in terms of evaluating free cash flow from companies that that were gold standard by looking at the debt markets by assessing the dynamics of does Oracle have funding. Are the the blue owls of the world sticking by.There's other folks that are uh you know, that's emblematic of a broader story ...

Core Insights - Inflation, interest rates, and economic uncertainty are compelling companies to focus on efficiency, making cash flow maintenance crucial for operations and growth [2] - Strong free cash flow allows companies to return capital to investors through dividends or share buybacks, enhancing shareholder value [2] Company Highlights - Gilead Sciences Inc. (NASDAQ: GILD) reported nearly $4 billion in free cash flow and $4.1 billion in operating cash flow in the latest quarter, driven by high-margin products and strong sales [3][4] - Gilead's diverse drug portfolio, including treatments for HIV and liver disease, supports consistent sales and enables ongoing R&D investment and attractive dividend distributions [4] - The company has maintained a dividend of 79 cents per share for the last four quarters, resulting in a dividend yield of 2.65%, above the healthcare sector average, with a low payout ratio of around 49% [4] - Gilead's shares have increased nearly 30% this year, with analysts projecting an additional 9.5% upside [5] Investment Opportunities - Companies like Gilead Sciences, Applied Materials, and Qualcomm are noted for their solid cash flow and capital returns, making them attractive to investors in the current economic climate [6]

At Cash Flow Club , we focus on businesses with strong cash generation, ideally with a wide moat and significant durability. When these companies are bought at the right time, that can be highly rewarding for us. If you are interested in joining our community, start right here !Broadcom Inc. ( AVGO ) reported its most recent earnings results on Thursday afternoon. The company delivered strong growth and beat estimates on both lines. Nevertheless, I'm not very bullish, as Broadcom is farJonathan Weber holds ...

Company Overview - Eastman Chemical Company is a leading specialty materials producer with a global footprint and a diversified product portfolio, focusing on innovation in specialty chemicals for high-growth markets such as transportation, building and construction, and advanced electronics [6] - The company generates revenue through the manufacture and sale of high-value specialty chemicals and materials, serving a broad customer base across various sectors including transportation, construction, electronics, agriculture, and consumer goods [9] Financial Performance - Eastman Chemical reported a revenue decline of 11% to $2.2 billion and a significant drop in EBIT from $329 million to $188 million year-over-year, attributed to lower volume across all segments and reduced asset utilization [11] - Despite the revenue decline, the company maintained strong operating cash flow of $402 million, supported by aggressive working-capital reductions and $200 million of inventory drawdowns [11] - The company returned $146 million to shareholders through dividends and buybacks [11] Market Position - As of the latest report, Eastman Chemical's shares were priced at $60.51, reflecting a 41% decline over the past year, significantly underperforming the S&P 500, which increased by 13% during the same period [3] - The company's market capitalization stands at $6.9 billion, with a trailing twelve-month (TTM) revenue of $9 billion and a net income of $699 million [4] Investment Sentiment - Atlantic Investment Management fully exited its position in Eastman Chemical during the third quarter, selling approximately 134,710 shares valued at $10.1 million, indicating a shift in investment sentiment towards the company [2][11] - The exit by Atlantic suggests that at least one value investor perceives better opportunities elsewhere, despite Eastman's diversified portfolio and disciplined cash generation efforts [12]

Core Viewpoint - Boeing is optimistic about its business outlook for 2026, expecting increased deliveries of its 737 and 787 jets, which will significantly impact cash flow and productivity improvements [1][2]. Group 1: Financial Performance - Boeing's stock rose over 6% following positive comments from the CFO regarding future deliveries [2]. - The company anticipates positive free cash flow in the "low single digits" for the upcoming year, marking a potential turnaround as it has not reported an annual profit since 2018 [2]. - Cash margins are expected to receive a "pretty significant boost" through 2030 due to higher productivity [3]. Group 2: Delivery and Production - Boeing is on track for its highest annual delivery total since 2018, driven by a strong delivery pace in October [4]. - The company returned to cash-positive territory for the first time in nearly two years in October, attributed to increased jetliner deliveries [4]. - The Federal Aviation Administration's lifting of restrictions has allowed Boeing to expedite the certification of some 737 Max and 787 Dreamliner planes [4]. Group 3: Future Expectations - The certification for the 737-10 aircraft, which has faced delays, is expected to be completed later in 2026 [2]. - CEO Kelly Ortberg noted that the company is beginning to see positive changes in its business, including reduced quarterly losses [3].

Core Insights - Danaher Corporation's third-quarter 2025 adjusted earnings of $1.89 per share exceeded the Zacks Consensus Estimate of $1.71, marking a 10.5% year-over-year increase [3] - The company reported net sales of $6.05 billion, surpassing the consensus estimate of $6.00 billion, with a year-over-year growth of 4.5% [3] - The overall core sales increased by 3% year over year, with foreign-currency translations contributing positively by 1.5% [4] Segment Performance - Life Sciences segment revenues reached $1.79 billion, a 0.5% increase year over year, although core sales decreased by 1% [5] - Diagnostics segment revenues totaled $2.46 billion, up 4% year over year, with core sales increasing by 3.5% [6] - Biotechnology segment revenues were $1.80 billion, reflecting a 9% year-over-year increase, with core sales rising by 6.5% [7] Margin and Profitability - Danaher's cost of sales rose by 5.5% year over year to $2.53 billion, while gross profit increased by 3.6% to $3.52 billion, resulting in a gross margin of 58.2% [8] - Operating profit surged by 20.5% year over year to $1.15 billion, with the operating margin expanding to 19.1% from 16.5% [9] Balance Sheet and Cash Flow - At the end of the third quarter, Danaher had cash and equivalents of $1.53 billion, down from $2.08 billion at the end of 2024, while long-term debt increased to $16.8 billion [10] - The company generated net cash of $4.30 billion from operating activities in the first nine months of 2025, a decrease from $4.67 billion in the previous year [11] Future Outlook - For the fourth quarter, Danaher anticipates adjusted core sales from continuing operations to grow in the low single digits year over year, with adjusted earnings expected to be between $7.70 and $7.80 per share [12] - Estimates for the stock have trended downward, with a consensus estimate shift of -9.79% over the past month [13] Investment Scores - Danaher currently holds a subpar Growth Score of D and a Momentum Score of F, with an aggregate VGM Score of F, indicating it is in the bottom 40% for value investors [14]

Core Insights - Viasat, Inc. (VSAT) reported mixed results for Q2 fiscal 2026, with a bottom line that exceeded Zacks Consensus Estimate but a top line that fell short [1] - Year-over-year revenue growth was driven by government satcom and aviation services in the Communication Services segment, along with growth in information security and cyber defense in the Defense and Advanced Technologies segment [1] Financial Performance - Viasat incurred a net loss of $61.4 million, or a loss of 45 cents per share, an improvement from a net loss of $137.6 million, or a loss of $1.07 per share, in the prior-year quarter [2] - Excluding non-recurring items, the company reported a non-GAAP net income of $12.6 million, or 9 cents per share, compared to a net loss of $29.4 million, or 23 cents in the prior-year period, beating the Zacks Consensus Estimate by 20 cents [3] Revenue Breakdown - Total revenues increased to $1.14 billion from $1.12 billion, although this figure missed the consensus estimate by $8 million [4] - Product revenues decreased to $319.4 million from $323.9 million year-over-year, while net sales from services rose to $821.5 million from $798.6 million [4] - Communication Services segment revenues were $837 million, up from $826 million, with growth in government satcom and aviation services offset by declines in maritime and U.S. fixed broadband [5] - Defense and Advanced Technologies segment revenues were $304 million, reflecting a 3% year-over-year increase, primarily due to growth in information security and cyber defense [6] Operational Metrics - Viasat reported an operating income of $35.8 million compared to a net loss of $24.7 million in the prior-year quarter [7] - Adjusted EBITDA increased to $385 million from $375 million year-over-year [7] Cash Flow and Liquidity - The company generated an operating cash flow of $282 million, up from $239 million in the prior-year period, attributed to improved operating performance and a decline in working capital [8] - As of September 30, 2025, Viasat had $1.2 billion in cash and cash equivalents, with a net debt of $5.5 billion [8] Future Outlook - For fiscal 2026, Viasat anticipates low single-digit revenue growth and flat adjusted EBITDA year-over-year, with the Communication Services segment expected to perform flat due to low double-digit growth in aviation services [9] - The Defense and Advanced Technologies segment is projected to see mid-teen revenue growth, driven by strong double-digit growth in information security and cyber defense [10]

Long term: Inflation and valuation splits.If subsidies meet higher tariffs, inflation pressure could creep back. Hard assets and cash-flow-rich companies may lead the next cycle.The best part? You can trade the ones you believe in directly onchain: https://t.co/MSexjlLhsK https://t.co/Iv55QfzLwX ...

Core Insights - Occidental Petroleum Corporation (OXY) is anticipated to report a year-over-year decline in both revenues and earnings for the third quarter of 2025, with results expected on November 10 after market close [1][5] - The company has consistently beaten earnings estimates in the last four quarters, averaging a surprise of 25.72% [1] Production and Earnings Expectations - OXY's production volumes for the third quarter are expected to improve compared to the previous quarter, driven by enhanced activity levels in the Permian region and increased production across all main operating areas [2] - The company anticipates production of 1,415-1,455 thousand barrels of oil equivalent per day (Mboe/d) for Q3 2025, with the Permian Resources segment expected to contribute 779-799 Mboe/d [6] Financial Performance Indicators - The Zacks Consensus Estimate for OXY's third-quarter revenues is $6.72 billion, reflecting a decline of 6.04% year-over-year, while the consensus for earnings is set at 48 cents per share, indicating a 52% decrease from the previous year [5][9] - Strong domestic demand for PVC may positively influence earnings, although market oversupply remains a concern [3] - OXY has been generating cash flow to reduce debts, retiring $7.5 billion in debt, which has lowered annual interest expenses by $410 million, likely benefiting earnings per share [4] Market Position and Earnings Prediction - The Zacks model does not predict an earnings beat for OXY this quarter, as the company holds a Zacks Rank of 4 (Sell) and an Earnings ESP of +0.89% [7][8] - Despite the anticipated decline in revenues and earnings, higher production volumes and effective cost management may help improve margins [9]

Core Insights - Generating cash is crucial for businesses, but effective cash allocation is essential for investment potential [1] - StockStory identifies companies that utilize cash flow effectively, highlighting companies to avoid and better alternatives [1] Company Summaries J. M. Smucker (SJM) - Trailing 12-Month Free Cash Flow Margin is 7.7% [2] - Current stock price is $105.60, trading at 11.1x forward P/E [4] Mohawk Industries (MHK) - Trailing 12-Month Free Cash Flow Margin is 5.5% [5] - Current stock price is $107.56, implying a valuation ratio of 11x forward P/E [7] Champion Homes (SKY) - Trailing 12-Month Free Cash Flow Margin is 7.6% [8] - Estimated sales growth of 2.2% for the next 12 months indicates a slowdown in demand [9] - Organic revenue growth has underperformed benchmarks, suggesting a need for product and strategy improvements [10] - Operating margin has decreased by 27.1 percentage points due to rising day-to-day expenses relative to revenue [10] - Return on Invested Capital (ROIC) is 2.2%, indicating management challenges in identifying attractive investment opportunities [10]